What you need to know about Lyme disease and its persistent symptoms

The term “chronic Lyme” is avoided, as it has been a source of scientific controversy for many years. Instead, the CDC refers to Post-Treatment Lyme Disease Syndrome (PTLDS), a recognized but still poorly understood reality.

According to Dr. John Aucott, Director of the Johns Hopkins Lyme Disease Research Center, six possible causes are currently being studied:

Infection-induced dysfunction or autoimmunity – the initial infection could disrupt the immune system, causing it to continue attacking the body.

Persistent bacterial infection or bacterial debris – the presence of residual bacteria or bacterial fragments that continue to stimulate the immune system.

Neural network alteration – changes in the central nervous system that may explain cognitive or neurological disorders.

Other tick-borne infections – certain co-infections (e.g., Babesia, Bartonella, Anaplasma) can worsen or prolong symptoms.

Other biological mechanisms yet to be discovered.

The graph accompanying the publication comes from the Johns Hopkins Lyme Disease Research Center, as part of Dr. John Aucott’s work on Post-Treatment Lyme Disease Syndrome (PTLDS). It clearly illustrates the difference between individuals with PTLDS and control participants regarding the frequency and severity of symptoms.

Complications from Lyme disease can significantly impair quality of life, sometimes catastrophically.

Furthermore, according to the Centers for Disease Control and Prevention (CDC), it is estimated that approximately 476,000 Americans are diagnosed with Lyme disease each year.

And since ticks know no borders or customs, this reality directly affects us here in Quebec. One only needs to look at the CDC’s distribution map of recorded Lyme disease cases in the United States to see that the most affected regions naturally extend toward our borders.

Ticks are now established in several regions of Quebec, and their expansion is accelerating due to climate change.

This reality represents a true public health emergency, as thousands of people continue to suffer through medical wandering or persistent symptoms. Patients in Quebec have the right to access adapted care, medical and social recognition, and safe, supervised clinical trials to improve their quality of life and advance research.

This is exactly what the AQML is calling for.